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ABSTRACT
Objective: Cognitive deterioration occurring in patients with probable Alzheimer’s disease is associated with a progressive loss of cholinergic neurons 
and a consequent decline in levels of acetylcholine in the brain. This study aimed to evaluate the acetylcholinesterase (AChE) inhibitory effects and 
cytotoxicity in SH-SY5Y cells of different parts of three lotus extracts.
Methods: AChE activity was quantified by spectrophotometry and cytotoxicity by flow 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide 
assay in SH-SY5Y cells exposed to extracts.
Results: All of the extracts had inhibitory effects to AChE at p<0.05, but Roseum Plenum stem extract could inhibit AChE more than 30% (p<0.05). The 
all of the extracts could be an increase SH-SY5Y cell proliferation, while Album Plenum flower extract could be cytotoxic on SH-SY5Y cells.
Conclusion: The extracts of lotus could be supplemented compound for cognitive deterioration or Alzheimer’s patients.
Keywords: Nelumbo nucifera Gaertn, Acetylcholinesterase activity, Human neuroblastoma cell line.
INTRODUCTION
The most common cause of dementia in the elderly associated with 
probable Alzheimer’s disease (AD) is one of the most common types 
of dementia, a chronic, progressive, disabling organic brain disorder 
characterized by disturbance of multiple cortical functions, including 
memory, judgment, orientation, comprehension, learning capacity, 
and language [1]. Patients with AD often have cholinergic deficits in 
association with the disease [2]. The symptoms of all types of dementia 
are presumed to be related to impaired neurotransmission and 
degeneration of neuronal circuits in the brain areas affected [3]. Cognitive 
deterioration occurring in patients with probable AD is associated with 
a progressive loss of cholinergic neurons and a consequent decline in 
levels of acetylcholine (ACh) in the brain.
The neurons can be subdivided into subclasses based on location, function, 
or chemistry. Neurons express a wide array of molecular components 
that may result in lethality if they, or their function, are adversely affected. 
To survive, a functioning nervous system is crucial. Therefore, neurons, 
synapses, signal molecules, and brain are needed. The endogenous signal 
molecules in the nervous system are called neurotransmitters, and their 
functions are chemically induced or attenuate the activity of other neurons 
or other organs in the body [4]. The storage of neurotransmitter in the 
vesicles has two main functions to protect the neurotransmitter from 
degradation and the fast release of the neurotransmitter. Neuromuscular 
transmission, parasympathetic signaling and cholinergic signaling in the 
central nervous system are dependent on ACh. ACh is rapidly hydrolyzed 
in the brain by acetylcholinesterase (AChE). Although AChE is found in 
higher concentrations in the brain tissue of patients with AD, there is 
evidence that known to receive cholinergic innervations [5].
The expression of both muscarinic and nicotinic ACh receptors has been 
reported in SH-SY5Y cells. The G-protein coupled muscarinic receptors 
are present on membranes of both undifferentiated and differentiated 
cells, though the levels and binding properties are differentially 
regulated according to the method of differentiation.
Lotus (Nelumbo nucifera Gaertn, N. nucifera) is considered as an important 
Thai traditional herb. All parts of N. nucifera are used as medicine 
for various medicinal purposes [6,7]. It has antidiabetic, antipyretic, 
anticancerous, anti-inflammatory, antimicrobial, antiobesity, antiviral, 
antioxidant, hepatoprotective, anti-thrombotic, anti-inflammatory, 
immunomodulatory, antidiarrheal, hypocholesterolaemic, anti-
arrhythmic, and antifertility activities properties [6,8-21]. The rhizome 
can be cooked and eaten as a common vegetable. The extract from 
rhizome showed antidiabetic and antiobesity attributes. The leaf is 
used for diverse applications for diarrhea, high fever, hemorrhoids, 
leprosy stopped bleeding [22], and stopping bleeding [23]. The seed 
is used as a diuretic, antivomiting, anti-inflammation, and cancer [24]. 
The numerous researches were reported that the extract of part lotus 
exhibits high antioxidative capacity [25], and the main compositions 
are phenolics including dopa, catachol, gallic acid, catechin, and 
epicatechin [26]. The major constituents that separate from the lotus 
plant are alkaloids (liensinine, neferine, nuciferine, remrefidine, 
and isoliensinine) and flavonoids (coclaurine, norcoclaurine, and 
quercetin) [27]. The aim of this study was to evaluate the AChE activity, 
and cytotoxicity on human neuroblastoma SH-SY5Y cell line was 
evaluated to assess dementia activity.
METHODS
Plant materials and extraction
The N. nucifera materials including of N. nucifera cv. Roseum Plenum 
(RP), N. nucifera cv. Album Plenum (AP), and N. nucifera cv. Hindu 
Lotus were collected from lotus museum, Rajamangala University of 
Technology Thanyaburi, Pathum Thani, Thailand. The different parts 
of lotus (leaf, stem, and flower) were macerated in 95% ethanol for 
7 days. The ethanolic extracts were evaporated and dried in a rotary 
evaporator.
Reagents
Dulbecco’s Modified Eagle Medium (DMEM), F12 medium, penicillin/
streptomycin, trypsin/EDTA, and 3-(4,5-dimethythiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTT) were purchased from Invitrogen 
(Invitrogen, USA). DMSO, phosphate-buffered saline (PBS), and 
dithiobisnitrobenzoic acid (DTNB) were purchased from ThermoFisher 
(Thermo Scientific, USA).
Determination of AChE activity
The activity of AChE in red blood cell (RBC) was determined according 
to slightly modified Ellman’s method as previously described [28-30]. 
The mixture was prepared by mixing 10 μL in each aliquot of 1:10 RBC 
and extracts added in 1.0 mL of 0.25 mM DTNB in phosphate buffer 
pH 7.4. This was pre-incubated for 5 min at room temperature, and 
the reaction was started with the addition 25 μL of acetylthiocholine 
iodide. The absorbance per minute (ΔA/min) of thiocholine product 
was determined by spectrometric absorption at 405 nm. The data 
were converted into the standardized units of nanomoles substrate 
hydrolyzed/min x mL, using the extinction coefficient for the yellow 
product (ε= 13.6 mM−1cm−1) to find the concentration. The AChE 
activity was calculated and expressed as U/L (AChE factor = 76,838). 
The experiment was run in triplicate. The AChE activities and AChE 
inhibitions were calculated by the following:






Where ΔA = the absorbance per minute of thiocholine product
  Ac = the delta absorbance per minute of control
  As = the delta absorbance per minute of sample
Cell culture and treatment
Human neuronal SH-SY5Y cells were cultured in DMEM/F12 with 10% 
fetal bovine serum (DMEM/F12) (Invitrogen, USA), and penicillin/
streptomycin (100 IU/mL) at 37°C in a humidified incubator with 5% 
CO2 atmosphere. SH-SY5Y cells were allowed to adhere at the bottom 
of a culture dish (60 mm) for 24 h before treatment with fresh medium 
containing 1 mg/mL of initial stock extracts for 24 h. SH-SY5Y cells 
treated with a vehicle that served as a control. For all experiments were 
performed in five replicates.
MTT reduction assay
SH-SY5Y cells were seeded in 6-well culture plate (2.5 × 104 cells per 
well) for 24 h. After SH-SY5Y cells were pre-treated with extracts. The 
end of the treatment, SH-SY5Y cells were incubated with 100 μL of MTT 
solution (5 mg/mL in PBS) for 2 h. Then, the medium was discarded 
and added formazan crystal products. The formazan crystal products 
were dissolved in 200 μL DMSO and stirred for 10 min. Absorbance 
was measured at 570 nm using a microplate reader. The results were 
compared with the untreated control, expressed as the percentage 
of cell viability. The data were obtained from five replicates. The 
percentage of cell viability was calculated from the following;
Cell viability (%) = (As/Ac) × 100
Where Ac = the absorbance of SH-SY5Y treated with vehicle medium
  As = the absorbance of SH-SY5Y treated with sample medium
Statistical analysis
All data were analyzed with a mean ± standard deviation of three 
independent experiment, descriptive statistics, t-test, and one-way 
analysis of variance using GraphPad Prism 6 version 6.01 (GraphPad 




The results of the AChE activity are shown in Fig. 1. The baseline AChE 
activity in 1:10 dilution of packed RBC was 10,321.94±379.03 U/L. At 
the 5 mg/mL concentration of leaf, stem, and flower ethanolic extracts 
of RP showed that ChE activity was 8,298.53±76.84, 6,480.02±319.90, 
and 9,476.72±247.00, respectively. The leaf, stem, and flower ethanolic 
extracts of AP showed that ChE activity was 9,579.17±117.37, 
8,759.56±277.04, and 9,527.94±76.84, respectively. The leaf and stem 
ethanolic extracts of HL showed that ChE activity was 9,451.10±203.29 
and 8,068.02±203.29, respectively. The extracts of Nelumbo nucifera 
(RP, AP, and HL) are shown mild AChE inhibition (14.36–27.64%) 
while the flower extract showed no symptoms of intoxication on 
AChE inhibition (10.57–28.86%), as shown in Fig. 1. The AChE activity 
decreased approximately to the one-third of the baseline activity (less 
than 33%), consistent with no symptoms of intoxication.
Cytotoxicity of SH-SY5Y cells
SH-SY5Y cells were incubated with extracts for 48 h. And then, MTT 
assay was carried out to determine the cell growth in response to 
extract treatment. The result showed that the growth of the cells was 
markedly inhibited from the extracts of flowers of AP and displayed 
a toxic response to the treatment, while the other samples could be 
increased SH-SY5Y cell proliferation, as shown in Fig. 2.
CONCLUSION
The extracts promoted a moderate cytotoxic effect against SH-SY5Y cell 
and did not show a significant AChE inhibitory activity. According to 
the study, we found that the ethanolic extracts of N. nucifera could be 
supplemented compound for cognitive deterioration or Alzheimer’s 
patients. However, further study on the effect of phytochemical 
composition in the different parts of N. nucifera. on the activity of AChE 
and cytotoxicity on SH-SY5Y cell.
Fig. 1: AChE inhibitory activities of Nelumbo nucifera extracts in 
packed red blood cell at a concentration of 10 mg/mL. Values 
were done in triplicate and represented mean±SD. *p<0.05, 
**p<0.01
Fig. 2: SH-SY5Y cell viability percentage of Nelumbo nucifera. 
Values are expressed as mean±SD. *p<0.005, compared with 
phosphate-buffered saline 
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